BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
1-Year Return
63.34%
This Quarter Return
+6.88%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$9.54B
AUM Growth
+$55.8M
(+0.59%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-17.1%
Top 10 Holdings %
Top 10 Hldgs %
82.65%
Holding
144
New
10
Increased
13
Reduced
15
Closed
7
Top Buys
| 1 |
Intellia Therapeutics
NTLA
|
$22.7M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$9.83M |
| 3 |
Merus
MRUS
|
$8.97M |
| 4 |
AAAP
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
|
$6.59M |
| 5 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$5.43M |
Top Sells
| 1 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
$274M |
| 2 |
Omeros
OMER
|
$11.5M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$9.52M |
| 4 |
ATYR
aTyr Pharma
ATYR
|
$8.42M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$5.46M |
Sector Composition
| 1 | Healthcare | 80.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDVN
26
DELISTED
MEDIVATION, INC.
MDVN
| $19.9M | 0.21% |
329,876
| – | – |
|
|
ACHN
27
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $19.3M | 0.2% |
2,475,515
| – | – |
|
28
Novavax
NVAX
$1.22B
| $17.3M | 0.18% |
118,963
| – | – |
|
|
PGNX
29
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $16.8M | 0.18% |
3,970,250
-380,558
| -9% | -$1.61M |
|
30
Xencor
XNCR
$590M
| $16.6M | 0.17% |
872,072
| – | – |
|
31
Halozyme
HALO
$8.7B
| $15.9M | 0.17% |
1,838,057
-93,000
| -5% | -$803K |
|
|
ARRY
32
DELISTED
Array Biopharma Inc
ARRY
| $15.3M | 0.16% |
4,310,666
| – | – |
|
33
Insmed
INSM
$30B
| $14.8M | 0.16% |
1,500,000
| – | – |
|
|
DSCI
34
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $14.8M | 0.16% |
3,752,390
| – | – |
|
35
Galapagos
GLPG
$2.04B
| $14.4M | 0.15% |
259,894
-43,500
| -14% | -$2.41M |
|
|
FOMX
36
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $14.2M | 0.15% |
2,241,702
| – | – |
|
|
BLUE
37
DELISTED
bluebird bio
BLUE
| $12.7M | 0.13% |
22,692
-4,555
| -17% | -$2.55M |
|
|
MRTX
38
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $12.4M | 0.13% |
2,269,198
-999,358
| -31% | -$5.46M |
|
39
TG Therapeutics
TGTX
$4.96B
| $12.1M | 0.13% |
2,003,991
| – | – |
|
40
Alkermes
ALKS
$4.79B
| $10.8M | 0.11% |
250,251
| – | – |
|
|
ACGN
41
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $10.7M | 0.11% |
51,529
+79
| +0.2% | +$16.4K |
|
42
Arcturus Therapeutics
ARCT
$449M
| $10.5M | 0.11% |
333,766
| – | – |
|
43
Ascendis Pharma
ASND
$12.1B
| $9.89M | 0.1% |
745,521
+240,000
| +47% | +$3.18M |
|
44
MacroGenics
MGNX
$116M
| $9.82M | 0.1% |
363,676
| – | – |
|
|
DERM
45
DELISTED
Dermira, Inc.
DERM
| $9.55M | 0.1% |
326,428
+51,428
| +19% | +$1.5M |
|
|
IMGN
46
DELISTED
Immunogen Inc
IMGN
| $9.29M | 0.1% |
3,015,353
-1,437,092
| -32% | -$4.43M |
|
|
47
Merus
MRUS
$4.92B
| $8.97M | 0.09% |
+1,122,859
| New | +$8.97M |
|
48
Ligand Pharmaceuticals
LGND
$3.27B
| $8.75M | 0.09% |
117,638
| – | – |
|
49
Agios Pharmaceuticals
AGIO
$2.05B
| $8.71M | 0.09% |
207,915
-100,000
| -32% | -$4.19M |
|
|
ZGNX
50
DELISTED
Zogenix, Inc.
ZGNX
| $8.05M | 0.08% |
1,000,000
| – | – |
|